Using real data for construction of a dynamical model to personalize androgen deprivation therapy in hormone-sensitive prostate cancer

The results of cooperation with IMBM team on modeling of HSCP treated with leuprolide will be presented. We proposed a new mechanistic model describing cancer growth represented by a level of prostate specific antigen in relation to testosteron dynamics and PK/PD of leuprolide. The model is confronted with clinical data from HSPC patients.

Hangouts Meet: at 12:00

meet.google.com/ufe-xfwd-jio

All welcome!